CClinicalTrials.gg
CompletedNCT06778577Updated Jan 16, 2025

The Efficacy of Suprascapular Nerve Radiofrequency and Intra-articular Steroid Injection in Frozen Shoulder Treatment

An interventional study of intra-articular corticosteroid injection (IACI) group and suprascapular nerve radiofrequency group (SCNRFT) in Frozen Shoulder, Radiofrequency Ablation Treatment and Intra-articular Injection, sponsored by Ankara University. Completed at 1 site in Turkey. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-01-16.

Sponsored by Ankara University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 3 months after the study started (first participant enrolled Aug 2021, registered Nov 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

The aim of this clinical study is to compare the effectiveness of suprascapular nerve pulsed radiofrequency and intra-articular steroid injection in patients with frozen shoulder (adhesive capsulitis). The main questions it aims to answer are:

  1. What is the effectiveness of intra-articular steroid injection in frozen shoulder?
  2. What is the effectiveness of suprascapular nerve radiofrequency in frozen shoulder?
  3. Should these two methods be used together in frozen shoulder?
02

Conditions studied

  • Frozen Shoulder
  • Radiofrequency Ablation Treatment
  • Intra-articular Injection

Browse trials for

Keywords

  • frozen shoulder
  • radiofrequency ablation treatment
  • intra-articular injection
03

In context

Bursitis

411 studies on the registry are indexed under Bursitis; 112 are open to participants now.

This study's enrollment of 80 is above the median of 45 across 371 interventional studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Ankara University is the lead sponsor of 312 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • unilateral side involvement.
  • ≥50% loss of passive ROM (external rotation or abduction) in the glenohumeral joint comparing to the unaffected side.
  • duration of symptoms ≥3 months.
  • age≥ 20year old.
  • Patients with VAS ≥4 before the procedure

Exclusion criteria

Exclusion Criteria:

  • ever received manipulation of the affected shoulder with/without anesthesia. systemic disease, severe degeneration, or trauma involving the shoulder. (ie, rheumatoid arthritis, osteoarthritis, history of injury to the labrum or articular cartilage or malignancies in the shoulder region, etc.)
  • neurologic diseases such as stroke or peripheral nerve neuropathy that have already affect the activity of shoulder.
  • pain or disorders of the cervical spine, elbow, wrist, or hand.
  • a history of drug allergy to local or corticosteroids.
  • Pregnancy or lactation.
  • Received corticosteroids, or hyaluronic acid intra-articular injection into the affected shoulder during the preceding 4 weeks.
  • Patients with VAS \<4 before the procedure
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    suprascapular nerve radiofrequency group (SCNRFT)

    SCNRFT+intra-articular steroid and local anesthesic injection with physiotherapy. Suprascapular nerve RFT: Ultrasound-guided SCNRFT 42ºC, 360ms. Ultrasound-guided intraarticular injection with 40mg triamcinolone+3 cc %0.5 bupivacaine. Physiotherapy: The physiotherapy program includes physical modalities (heat therapy and electric therapy) and therapeutic exercise. (stretching, mobilization and ROM exercise, and strengthening)

    Procedure: suprascapular nerve radiofrequency group (SCNRFT)

  • Active comparator
    intra-articular corticosteroid injection (IACI) group

    IACI with physiotherapy. Intra-articular steroid+local anesthesic injection: Receive intra-articular corticosteroid injection. Ultrasound-guided IACI with 3c.c. 0.5% bupivacaine and 40mg triamcinolone. Physiotherapy: The physiotherapy program includes physical modalities (heat therapy and electric therapy) and therapeutic exercise. (stretching, mobilization and ROM exercise, and strengthening)

    Other: intra-articular corticosteroid injection (IACI) group

Interventions

  • Otherintra-articular corticosteroid injection (IACI) group

    IACI can provide rapid effect in pain reliving, reducing inflammation and improving ROM that could increase the compliance of exercise therapy.

  • Proceduresuprascapular nerve radiofrequency group (SCNRFT)

    SCNRFT is a new choice for treatment of frozen shoulder. The suprascapular nerve is the nerve that is most commonly affected in the condition of a frozen shoulder and it is for this reason that the suprascapular nerve is directly targeted by pulsed radiofrequency treatment. As radiology techniques advance, ultrasound-guided SCNB becomes more popular. It provides a cost and time-effective way to "tag" the nerve accurately without injury to the nerves or vessels.

06

What researchers measure

Primary outcomes

  1. Change of The Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Ask the patient to rate their current level of pain by placing a mark on the line.

    Time frame: baseline and at 4 weeks and 12 weeks after the beginning of the treatment.

Secondary outcomes

  1. The active ROM

    The maximal active ROMs of the affected shoulder will be measured using a goniometer under the guidelines of the American Academy of Orthopedic Surgeons. These measurements included abduction in the frontal plane, forward flexion, internal rotation, and external rotation with the arm at 0 degrees of abduction.

    Time frame: Baseline and at 4 weeks and 12 weeks after the beginning of the treatment.

  2. Change of scores of the Shoulder Pain and Disability Index (SPADI)

    The total SPADI score, which ranges between 0 and 100, is calculated by averaging the scores from the pain and disabilities subclasses.

    Time frame: Baseline and at 4 weeks and 12 weeks after the beginning of the treatment.

07

Study locations

1 site
  • Ankara University, Faculty of Medicine, Department of Anesthesiology and Reanimation, Department of Algology
    Ankara, 06230, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06778577
Lead sponsor
Ankara University
Responsible party
Dostalı Alıyev (Principal Investigator, Ankara University) — Principal investigator
First posted
Jan 16, 2025
Start date
Aug 15, 2021
Primary completion
Oct 10, 2022
Completion
Oct 20, 2022
Last update
Jan 16, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion